Huawei Cloud releases medical and health solutions, and Pangu model empowers five major medical and health scenarios

On August 10, the Huawei Cloud Medicine and Health AI Summit Forum kicked off in Boao, Hainan. Huang Jin, Vice President of Huawei Cloud (President of Strategy and Industrial Development Department), said at the meeting that national policies continue to increase the emphasis on biomedicine, and medical and health companies have also increased investment in scientific research and innovation, but there is still a gap compared with the international advanced level, especially in In the research and development of innovative drugs. However, the rapid development of domestic artificial intelligence has provided new opportunities for medicine and health to catch up.

"Huawei Cloud Vice President (President of Strategy and Industry Development Department) Huang Jin
"Huawei Cloud has full-stack independent AI innovation capabilities. We hope to work with customers in the medical and health industry to create China's own internationally renowned Pharmaceutical brands work together to benefit human health and promote the development of China's pharmaceutical and health industry. "Huang Jin said.
AI accelerates the transformation of China's pharmaceutical and health industry
In the view of Zhang Peng, Vice President and CMO of Huawei Cloud China, in recent years, the public has become more and more concerned about health, and online platforms have also rapidly extended to the pharmaceutical industry, which has made The space of pharmaceutical companies and offline retail pharmacies is constantly shrinking, and companies are in urgent need of rebuilding their own capabilities. Digital intelligence may become the key to breaking the situation
As a fellow traveler in the pharmaceutical and health industry, Huawei Cloud is committed to leveraging its accumulated digital transformation experience, security, and AI. The five major innovation capabilities of innovation, credibility, global layout and ecology empower the three major scenarios of life sciences, pharmaceutical and device companies, and medical health, and comprehensively accelerate the intelligent transformation of the pharmaceutical and health industry

1. Huawei Cloud AI helps pharmaceutical companies. R&D Innovation

• In view of the problems faced by pharmaceutical companies in drug discovery, clinical trials, and genetic analysis, Huawei Cloud AI is committed to solving the problems of "innovative drugs"
• Building a full link of research, production, supply, sales, and service.
• Build full-stack independent smart medical scenario capabilities to create AI applications before, during and after diagnosis

2. Pangu Drug’s large molecular model improves drug design efficiency

• Pangu Drug. Large molecular models increase drug design efficiency by 33%.

3. AI empowers the pharmaceutical and health industry

• AI injects innovative vitality into the pharmaceutical and health industry, opening up more new imaginations and possibilities
• Huawei Cloud. Create medical and health solutions and accelerate the high-quality development of the industry with four-layer innovation of "computing power innovation, digital intelligence innovation, security innovation, and application innovation"
• The Pangu model is oriented to drug research and development, smart medical care, gene sequencing, clinical research, and China. Five major scenarios of pharmaceutical application innovation

  

  1. You Peng, President of Huawei Cloud Big Data and Artificial Intelligence

You Peng revealed that the Pangu drug molecule model has been newly upgraded, adding target pocket discovery and molecular docking. , molecular attribute prediction, custom attribute modeling, molecular clustering, pocket molecule design, free energy perturbation, synthetic path planning, molecular optimization, molecular search and other top ten AI pharmaceutical core scenarios, increasing the efficiency of drug design by 33%. The optimized molecular binding energy is increased by more than 40%, accelerating the entire process in the early research stage, so that the "double ten law" no longer troubles drug research and development

2. Targeting the widespread use of genetic workflows and customized data analysis, high computing and storage requirements. To solve the problem, Pangu for Gene built the industry's first bioinformatics intelligent agent GenomeAgent, which can provide support for the omics analysis process of more than 40 scenarios. Through joint innovation of nucleic acid drug structure design and function prediction, the safety of drugs has been effectively improved. and effectiveness.
3. In the field of traditional Chinese medicine, the Pangu large model can also help it realize the upgrade of the entire industry chain of planting, research and development, production, circulation, and sales, accelerate the research and development of traditional Chinese medicine, and at the same time integrate millions of levels of traditional Chinese medicine knowledge. Wanfang prescriptions and diagnosis and treatment records can realize intelligent consultation, health Q&A, traditional Chinese medicine education and other scenarios, so that the profound traditional Chinese medicine culture can be better passed on.

You Peng said, "The digital intelligence of the medical and health industry. The road ahead is long and arduous. As a deep cultivator of basic innovation, Huawei Cloud is committed to providing core technologies such as key computing power, technology, and large models. It goes deep into the industry and its core applications, and works with industry partners to build a prosperous large model ecosystem. ”

4. Industry leaders are transforming intelligently on Huawei Cloud

With continuous efforts in technological innovation and continuous exploration of industry scenarios, Huawei Cloud is becoming a reliable choice for digital intelligence upgrades in more and more medical and health industries. Partners. So far, many pharmaceutical customers including Runda Medical, Tasly Group, Microchip Biotech, Chinese Academy of Medical Sciences, etc. have chosen Huawei Cloud.

天士力與華為雲共建的“數智本草・中藥研發大模型”，賦能中藥研發中的智能問答、報告生成、交互計算，中藥診療，中藥教育等場景。天士力國際基因網路藥物創新中心總經理王文佳表示，中藥產業加速發展是政策與市場雙重導向，天士力長期致力於中藥數智化研發，將攜手華為雲驅動現代中藥走向數智中藥。

1. 天士力國際基因網絡藥物創新中心總經理王文佳

在AI 時代，許多百年老字號也邁上數智轉型的快車道，雲南白藥攜手華為雲共同打造了“雷公大模型”， 構建普惠的中醫藥知識服務平台與專業的中藥材產業服務平台，建立標準化、系統化的中醫藥產業大模型範式，協助雲南生醫產業向高階化、智慧化、綠化方向轉型升級。雲南白藥集團數位策略科學家、數智中心總經理李少春表示：「雲南白藥集團與華為雲將以共建中醫藥產業大模型為契機，攜手全產業鍊夥伴，堅持傳承與創新結合，借助科技創新之力啟動中醫藥產業的潛在力量，推動大數據模型與人工智慧技術在中醫藥領域的廣泛應用與縱深突破，加速中醫藥產業數位轉型，振興中國藥企品牌。集團數位策略科學家、數智中心總經理李少春

潤達醫療建構了「資料要素+ 人工智慧」 的數智化醫療解決方案

基於多模態AI 能力中台，實現了全結構化的資料中心
2. 建構了醫療健康智能體，包括醫療從業人員的AI 醫療助理「良醫」 和麵向大眾使用者的AI 健康助理「小慧」
3. 數智化解決方案已經在上海長海醫院、溫州醫科大學第一附屬醫院等60 多家醫療機構以及柳藥集團等醫藥企業實現應用落地
4. 希望未來「良醫」、「小慧」 能夠走進更多的醫療機構，提供更優質、高效的解決方案
6. 潤達醫療智慧醫療事業部CTO 張楠

   

The above is the detailed content of Huawei Cloud releases medical and health solutions, and Pangu model empowers five major medical and health scenarios. For more information, please follow other related articles on the PHP Chinese website!